Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Thermo Fisher Scientific Inc., liquidity ratios

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Current ratio 1.66 1.75 1.48 1.50 2.13
Quick ratio 1.14 1.27 1.06 1.00 1.63
Cash ratio 0.42 0.58 0.50 0.33 1.00

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Thermo Fisher Scientific Inc. current ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Thermo Fisher Scientific Inc. quick ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Thermo Fisher Scientific Inc. cash ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024.

Current Ratio

Thermo Fisher Scientific Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Current assets 22,137 24,589 25,229 20,113 21,957
Current liabilities 13,332 14,012 17,010 13,436 10,304
Liquidity Ratio
Current ratio1 1.66 1.75 1.48 1.50 2.13
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.66 0.87 0.96 0.79 0.84
Amgen Inc. 1.26 1.65 1.41 1.59 1.81
Bristol-Myers Squibb Co. 1.25 1.43 1.25 1.52 1.58
Danaher Corp. 1.40 1.68 1.89 1.43 1.86
Eli Lilly & Co. 1.15 0.94 1.05 1.23 1.40
Gilead Sciences Inc. 1.60 1.43 1.29 1.27 1.40
Johnson & Johnson 1.11 1.16 0.99 1.35 1.21
Merck & Co. Inc. 1.36 1.25 1.47 1.27 1.02
Pfizer Inc. 1.17 0.91 1.22 1.40 1.35
Regeneron Pharmaceuticals Inc. 4.73 5.69 5.06 3.56 3.63
Vertex Pharmaceuticals Inc. 2.69 3.99 4.83 4.46 4.33
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.24 1.27 1.30 1.36 1.37
Current Ratio, Industry
Health Care 1.11 1.13 1.15 1.21 1.20

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= 22,137 ÷ 13,332 = 1.66

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Thermo Fisher Scientific Inc. current ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.

Quick Ratio

Thermo Fisher Scientific Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents 4,009 8,077 8,524 4,477 10,325
Short-term investments 1,561 3
Accounts receivable, less allowances 8,191 8,221 8,115 7,977 5,741
Contract assets, net 1,435 1,443 1,312 968 731
Total quick assets 15,196 17,744 17,951 13,422 16,797
 
Current liabilities 13,332 14,012 17,010 13,436 10,304
Liquidity Ratio
Quick ratio1 1.14 1.27 1.06 1.00 1.63
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.43 0.63 0.69 0.56 0.60
Amgen Inc. 0.81 0.99 0.95 1.06 1.30
Bristol-Myers Squibb Co. 0.91 1.04 0.87 1.20 1.28
Danaher Corp. 0.83 1.18 1.30 0.89 1.36
Eli Lilly & Co. 0.59 0.52 0.63 0.80 0.85
Gilead Sciences Inc. 1.20 1.06 0.99 0.95 1.08
Johnson & Johnson 0.78 0.82 0.71 1.04 0.91
Merck & Co. Inc. 0.84 0.68 0.93 0.73 0.58
Pfizer Inc. 0.74 0.50 0.80 1.00 0.78
Regeneron Pharmaceuticals Inc. 3.86 4.82 4.16 2.98 2.86
Vertex Pharmaceuticals Inc. 2.17 3.60 4.46 4.04 4.02
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.82 0.85 0.91 0.98 0.98
Quick Ratio, Industry
Health Care 0.80 0.82 0.86 0.89 0.89

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 15,196 ÷ 13,332 = 1.14

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Thermo Fisher Scientific Inc. quick ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level.

Cash Ratio

Thermo Fisher Scientific Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents 4,009 8,077 8,524 4,477 10,325
Short-term investments 1,561 3
Total cash assets 5,570 8,080 8,524 4,477 10,325
 
Current liabilities 13,332 14,012 17,010 13,436 10,304
Liquidity Ratio
Cash ratio1 0.42 0.58 0.50 0.33 1.00
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.14 0.34 0.31 0.28 0.30
Amgen Inc. 0.52 0.60 0.59 0.66 0.91
Bristol-Myers Squibb Co. 0.46 0.55 0.42 0.78 0.83
Danaher Corp. 0.31 0.71 0.71 0.32 0.82
Eli Lilly & Co. 0.12 0.11 0.13 0.26 0.29
Gilead Sciences Inc. 0.83 0.64 0.57 0.56 0.65
Johnson & Johnson 0.49 0.50 0.42 0.70 0.59
Merck & Co. Inc. 0.48 0.28 0.54 0.34 0.30
Pfizer Inc. 0.48 0.27 0.54 0.73 0.47
Regeneron Pharmaceuticals Inc. 2.28 3.17 2.46 1.45 1.33
Vertex Pharmaceuticals Inc. 1.72 3.16 3.93 3.51 3.55
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.45 0.47 0.52 0.58 0.59
Cash Ratio, Industry
Health Care 0.38 0.42 0.47 0.50 0.51

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 5,570 ÷ 13,332 = 0.42

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Thermo Fisher Scientific Inc. cash ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024.